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Tumor necrosis factors (TNFs) play a crucial role in mammalian signal transduction 
pathways for cell proliferation, survival, and differentiation. Genome sequencing 
projects provide a unique opportunity for genome-wide recognition of TNF-related ligand 
proteins. Genome-wide screening for TNF-related proteins in human and Arabidopsis 
was carried out using protein fold recognition scheme. In the protein-structure threading 
scheme, sequence-structure models are evaluated using contact energy score based on 
Miyazawa-Jernigan and Li-Tang-Wingreen models [ 1, 2] . Prescreening potential TNF 
structures on the basis of secondary structure composition reduces the search space and 
shifts the score distribution of the selected candidates to a higher score region. To 
investigate the influence of sequence length on threading results, protein fold recognition 
was conducted on human and Arabidopsis complete protein sequences of different 
lengths. The test on known TNFs from diverse species indicates that about 83% of TNFs 
can be identified; the test on human genome sequences shows that about 80% of known 
TNFs can be recognized. Integration of secondary structure profiling into the scheme 
improves performance by adjusting local sequence-structure relationship. However, this 
improvement largely depends on the accuracy of the secondary-structure prediction. 
Average scoring performs better than maximal scoring in model evaluation and selection. 
This genome-wide search scheme was used to search potential TNF-like signal proteins 
in Arabidopsis genome. Possible candidates in human and Arabidopsis genomes are 
discussed. These results demonstrate that structure based methods can contribute to 
functional prediction on a genome-wide scale. 
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Introduction 
Tumor necrosis factor (TNF) family members play a critical role in signal 
transduction pathways for cell proliferation, survival, and differentiation. TNF family 
members recognize and bind specific death receptors on cell surfaces, which can be 
converted to intracellular signals and trigger caspase activation and apoptosis [3]. Different 
TNF-ligands and TNF-receptors interactions, for instance the interaction between TNF-RI 
and TNF, between TNF-RII and TNF, and between Fas and Fast, may specify different 
triggering mechanisms leading to cell death [4] . TNF/TNF receptor superfamily members 
also play a central role in the rapid and potent signaling process that coordinates 
physiological responses of immune systems against pathogens [5]. Moreover, TNF/TNFR 
superfamily members are involved in pathogenesis of a variety of diseases including cancer, 
autoimmune disorders, atherosclerosis, osteoporosis, obesity, type II diabetes [5]. Therefore, 
TNF/TNFR superfamily members are very important for understanding of molecular 
mechanisms of cell survival and offer potential targets for clinical intervention. 
A major challenge in functional genomics research is to discover new molecular 
mechanisms or pathways by comparing different genomes. So far TNF related ligand 
proteins and TNF/TNFR related molecular mechanism have never been identified in plants. 
Becraft et al. identified in maize a TNFR-like receptor kinase which plays an important role 
in plant cell differentiation and development [6] . The extracellular domain contains a 
cysteine-rich region similar to the ligand-binding domain of mammalian TNF receptors. It is 
hypothesized that a signal transduction mechanism similar to TNF-TNFR might exist in 
plants. The key to the exploration is to search for TNF like ligand peptide in plant genomes. 
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Fig. 1. Crystal structure of Apo2L/Trail in complex with death receptor-5, illustrating 
trimeric symmetry of TNF ligand and TNF receptor binding [7] 
The successes of human and other genome sequencing projects provide a unique , 
opportunity to study TNF and TNF/TNFR superfamily members. TNF family members 
share a similar trimeric protein tertiary structure with ~3-sandwich structure formed by anti-
parallel ~3 strands [S ] . The unique structural attributes of TNF related ligand proteins are 
crucial for specific ligand-receptor recognition, binding, and trimerization. In the protein 
structure classification database SCOP, TNF-like fold belongs to all beta protein class [7]. It 
is of great interest to recognize TNF related ligands in the human genome based on structural 
properties of the known TNFs to see whether there are other proteins with a similar structure. 
TNF related proteins share 25 ~ 3O% sequence similarity; the external surfaces of ligand 
trimers show little sequence similarity, presumably due to ligand-receptor specificity [5, 8]. 
Under this circumstance, the sequence similarity based functional prediction approach, such 
as BLAST, is not as robust and reliable as in the higher sequence similarity region [9]. 
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However, proteins with low sequence similarity may share a similar tertiary fold type. For 
instance, the structures of TRAIL-DRS complex and LTa/TNFRl complex show a 
significant structural conservation although the two have little sequence similarity [10]. 
Therefore, structural information may provide more powerful approach to molecular target 
recognition problem. 
Structure-based functional prediction is aimed at predicting protein functions based 
on protein structural similarity. Protein structure threading, a type of methods for protein 
fold recognition, is able to search putative protein sequences with a similar fold to known 
protein structures. The fundamental algorithm of protein structure threading is that a query 
protein sequence is optimally aligned to each of a library of known protein three dimensional 
structures, and then the resulting models is ranked by energy or other criteria to identify the 
most likely structure model (Fig 2). Optimized sequence-structure alignment and scoring 
function are two major components in protein threading schemes. Gapless sequence- 
structure alignment was utilized to generate non-native decoy structure sets in order to ensure 
a variety of conformations of a sequence to be comparable [ 11 ]. However, disallowance of 
gap is too stringent for generating alternative folds. Gap-allowed sequence-structure 
alignment can relax the stringency and generate relatively flexible alternative folds. On the 
other side, gap-allowed sequence-structure alignment leads to sequence dependency of whole 
ensemble of conformations. 
A reasonable coarse grained potential function is crucial for examining compatibility 
between query sequence and template structure and for distinguishing native or native-like 
protein fold from a large set of decoy structures. Dill et al. proposed the hydrophobic- 
hydrophilic (HP) model on cubic lattice based on the assumption that the hydrophobic 
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interaction is the dominant driving force ofprotein folding [12]. In the HP model, amino 
acids are classified as hydrophobic (H) and hydrophilic (P). Energy gain 1 is assigned to 
each ofhydrophobic-hydrophobic (H-H) contact, and energy gain 0 is assigned to each of 
hydrophobic-hydrophilic (H-P) contact or hydrophilic-hydrophilic (P-P) contact. An optimal 
conformation can be achieved by maximizing number of H-H contacts. Miyazawa and 
Jernigan estimated protein effective pairwise inter-residue contact energies (MJ model) for 
all combinations of twenty amino acids from 3-D protein structures using quasi-chemical 
approximation [1]. M-J contact energies are strongly relevant to residue type and clearly 
specify contact energy of every combination of amino acids. Li et al. decomposed 
Miyazawa-Jernigan 20X20 inter-residue contact energy matrix, and found that MJ matrix can 
be accurately reconstructed from its first two principle components [2]. The twenty q values 
derived from MJ matrix are associated with twenty natural amino acids; the twenty q values 
can be grouped into two clusters corresponding to hydrophobic and hydrophilic. Practically, 
the q values can be utilized as an inherent amino acid physico-chemical property to encode 
protein sequences and compute contact energy. Cao et al. proposed a protein structure 
threading scheme based on the work of Miyazawa et al [1] and Li et al [2], with protein 
structures being represented by contact matrices and protein sequences being represented by 
twenty q values [13]. 
In the present study, the protein threading scheme was applied to genome-wide 
recognition of TNF related signal proteins in human and Arabidopsis genomes. Genome- 
wide secondary structure properties and their application in fold recognition of TNF related 
proteins are systematically investigated. Threading scoring and its relationship with 
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sequence length are also addressed in this research. Moreover, pattern classification 
algorithms are attempted to discriminate and reduce competitive false positives. 
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Materials and methods 
1. Secondary structure composition prediction 
Human and Arabidopsis genome predicted protein sequence sets were downloaded 
from National Center of Biotechnology Information web site (http://www.ncbi.nlm.nih.gov~.
The human genome predicted protein sequence set has 16500 sequences; the Arabidopsis 
genome predicted protein sequence set has 22650 sequences. The 81 known TNF protein 
sequences from a variety of species were searched and downloaded from Swiss-Prot protein 
database (http://www.ebi.ac.uk/swissprot), including 19 human TNF protein sequences. Two 
secondary structure prediction programs, PROF [14] and PSIPRED [15], were automated for 
genome scale prediction. The secondary structure prediction results from PROF and 
PSIPRED were processed to calculate secondary structure content. 
2. Protein structure threading scheme 
The known TNF 3-D structures in fold library are taken from Protein Data Bank 
(PDB) (http://www.resb.org/pdbn. The TNF structures in fold library are listed in table 1. 
Only single chain was used as structure template in the fold library. The 17 structures in the 
fold library belong to 6 unique TNF superfamily members (TNFSFs), i.e. human and mouse 
TNF-a (Cachectin), human TNF-(3 (Lymphotoxin a), human CD40, human Trail/APO-2L 
(TNFSFIO), Human BLYS (TNFSFI3B), mouse RANKL (TNFSFII). Among the 17 
structures, 4TSV, STSW (A), lA8M (A), and 2TUN (A) are human TNF-a mutants; 1D4V, 
1DOG, and 1DU3 are derived from TRAIL-DRS complex [16, 17, 18]. 
The principle of our protein structure threading scheme is illustrated in figure 2. In 
our scheme, the template structures in the fold library are represented as contact matrices 
[19]. Two residues are defined to be in contact if distance between centers of position (COP) 
of the two residues is less than 6.5 ~, where definition of COP is the average position of the 
non-hydrogen atoms in the residue, excluding the CR atom. If two residues i and j are in 
contact, then 1 is assigned to the corresponding element cl~ in contact matrix C. Otherwise, 0 
is assigned to the element. The first dominant eigenvector of contact matrix is used to 
represent template structure because the first dominant eigenvalue is much larger in 
magnitude than the rest in the eigenvalue spectrum and contact matrix can be accurately 
reconstructed with the first dominant eigenvector [2] . In this scheme, sequences are 
represented with twenty q values corresponding to 20 natural amino acids derived from 
Miyazawa-Jernigan effective inter-residue contact energy model [ 1 ] . Alignments between 
query sequence and template sequence are generated by global gap-allowed dynamic 
programming. The contact energy based raw score is applied to evaluate intermediate query-
template alignments. This process is iterated until converge of the raw score. 
In this scheme, local secondary structure preference is taken into account by 
comparing secondary structure profiles between query sequence and template sequence in an 
intermediate alignment in every step of the iteration process. The adjusted raw score is 
computed as follows, 
Mright — Mwrong Adusted raw score = (1 + a x ) x rawscore 
Maligned 
Where (1 + a (Nright-Nwrong)/Naligned) is defined as enhancement factor. Maligned is the 
number of residues aligned to the structure, Nright is the number of residues where the 
secondary structure (helix, sheet or loop) of the template agrees with the result from 
secondary structure predictions and N~ong is the number of residues where they disagree. The 
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secondary structure profiles of query sequences are predicted by PROF, and the secondary 
structure profiles of template structures are from their PDB files. 
In order to reduce the bias arising from amino acid composition, a number of random 
sequences are generated by random shuffling (Fig. 3). Relative score and Z score are 






Relative Scope = 
Enative - Eavera g e 
For each query sequence, 17 relative scores are generated corresponding to 17 template TNF 
structures. Two scoring approaches, maximal scoring and average scoring, are attempted in 
this study. Maximal scoring is to rank query sequences using the maximal score among the 
17 relative scores; and average scoring is to rank query sequences using average of the 17 
re ative scores. 
9 
Table 1. The known TNF structures in the fold library 
PDB ID Description 
1 TNF (A) Human TNF-a (Cachectin) 
4TSV Human TNF-a (Cachectin) mutant (Deletion Of N-
Terminal Seven Residues, Leu-29-Ser, Ser-52-Ile, 
Tyr-56-Phe) 
STSW (A) Human TNF-a (Cachectin) mutant (Arg-3l-Asp) 
lA8M (A) Human TNF-a (Cachectin) mutant (Ala-84-Val) 
2TUN (A) Human TNF-a (Cachectin) mutant 
2TNF (A) Mouse TNF-a 
1TNR (A) Human TNF-(3 (Lymphotoxin a) 
IALY Human CD40 
1DG6 Human TraiUAPO-2L (TNFSFIO) 
1D4V (B) Human TraiUAPO-2L (TNFSFIO) (derived from 
Trail-Dr5 complex) 
1DOG (A) Human Trail/APO-2L (TNFSFIO) (derived from 
Trail-Dr5 complex) 
1D2Q Human Trail/APO-2L (TNFSFIO) 
1DU3 (E) Human Trail/APO-2L (TNFSFIO) (derived from 
Trail-Dr5 complex) 
1JH5 (A) Human BLYS (TNFSFI3B) 
1KXG (A) Human BLYS (TNFSFI3B) 
IIQA (A) Mouse RANKL (TNFSFII) 
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Fig. 2. Generation of empirical distribution using random sequence shuffling 
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Results 
The general strategy for genome wide TNF recognition includes two stages. In the 
first stage, the unique secondary structure feature of TNF is utilized to screen protein 
sequences in whole genome scale, and to narrow down number of candidates by removing 
protein sequences whose predicted secondary structure composition does not match the 
known TNFs' . In the second step, the protein structure threading scheme is applied to 
choose candidates which have similar tertiary protein structure with the known TNF 
structures. 
1. Secondary structure composition of known TNFs and human genome 
The known TNF structures share similar secondary structure component composition, 
i.e. high percentage of ~i-sheet and coil and low percentage of a-helices. Taking this 
advantage, an initial screening was carried out based on secondary structure component 
composition. PSI-FRED was automated to fulfill large-scale prediction of secondary 
structure component composition of the known TNFs, human and Arabidopsis genome 
protein sequences. The distributions of predicted secondary structure component a-helix, ~3-
sheet, and coil of the known TNFs are different from those of human genome sequences (Fig. 
3). In real TNF structures, ~-sheet and coil account for about SO% and 50%, while 
percentage of a-helix maybe neglected. For the known TNFs, the a-helix composition 
distribution mainly ranges between 0 ~ 3 0%; the ~-sheet composition distribution mainly 
ranges between 12 ~ 38%; and the coil composition distribution mainly ranges between 44 
68% (Fig. 1). As compared with secondary structure composition of the crystallized TNF 
proteins, it should be aware that the PSI-FRED prediction is biased to higher percentage of a-
helix and lower percentage of ~3-sheet. The major reason we used PSI-FRED is that PSI-
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PRED is computationally less demanding than PROF, which is very important for genome-
wide secondary structure prediction. The secondary structure composition distributions of 
genome sequences are much broader than those of the known TNFs (Fig. 1). It is interesting 
that the secondary structure composition distributions are very similar between human 
genome and Arabidopsis genome (Fig. 4). The following criteria were applied to screen 
human and Arabidopsis genome sequences: 0% < a-helix composition < 30%, 20% < ~-sheet 
composition < SO%, and 40% < coil composition < 70%. With these criteria, 2970 protein 
sequences were selected from 16500 protein sequences in human genome; 4174 protein 
sequences were selected from 22650 protein sequences in Arabidopsis genome. Secondary 
structure composition based initial screening can not only narrow down number of genome 
putative protein sequences for threading which is computationally very demanding, but also 
improve overall quality of the selected sequence population (Fig. 5). The relative score 
distribution of the selected human sequences shifted to higher relative score region as 
compared with the score distribution of the original sequence population (Fig. SB). These 
results suggest that the initial screening based on secondary structure composition is effective 
in screening out decoy protein sequences. Moreover, these results imply that local sequence-
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Fig. 3 Distribution of the predicted secondary structure component composition of known 
human TNFs (gray bars) and human genome protein sequences (white bars). (A) alpha helix; 
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Fig. 4. Comparison in distribution of the predicted secondary structure component 
composition between human genome (red) and Arabidopsis genome (blue). (A) alpha 
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Fig. 5 Comparison in relative score distribution of human genome protein sequences before 
and after secondary structure composition based initial screening. (A) histogram of number 
of sequences, y-axis label is number of sequences; (B) histogram of frequency, y-axis label is 
frequency of sequences in a bin over total number of sequences . 
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2. Integration of secondary structure profiling can improve fold recognition performance 
Local sequence-structure relationship has an important impact on protein global 
folding. Therefore, taking this factor into account is potentially meaningful for refinement of 
global fold recognition. Practically, in this threading scheme, secondary structure profiling is 
integrated into the threading scheme in order to adjust local sequence-structure relationship 
while pursuing global optimization. Table 2 shows comparison in relative score rank of the 
known human TNFs between the scheme with and without secondary structure profiling 
adjustment. The scheme with or without secondary structure profiling adjustment was run on 
the selected 2790 human genome protein sequences. For top nine TNFs, there is no 
significant change in rank between with and without secondary structure profiling adjustment. 
EDA is still within the recognizable range although the rank of EDA changes from 10th to 
19th with secondary structure profiling adjustment. The ranks of TNF 13b and CD70 are 
significantly improved, changing from 66th to 10th and 95th to 15th, respectively. The ranks of 
TNF9 and TNF4 are also improved although the two ligands are still unrecognizable. 
Generally, secondary structure profiling adjustment can improve performance of this scheme, 
particularly for candidates which cannot be recognized solely based on global contact energy. 
It should be mentioned that the above results are based on the secondary structure profiles 
predicted by PROF [ 14] . It has been noticed that secondary structure profiles predicted by 
different algorithms may have an impact on performance of the threading scheme. Two 
secondary structure prediction algorithms, PSI-PRED and PROF, were compared in their 
influences on the threading results of 81 known TNFs from different species and 19 known 
human TNFs (table 3). Table 3 shows that more TNFs can be recognized by the threading 
scheme with PROF secondary structure profiles than with PSI-PRED profiles. This 
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difference maybe resulted from our observation that PSI-PRED overestimates percentage of 
a-helix in TNFs and underestimates percentage of ~3-sheet in TNFs (Fig. 6). The crystallized 
TNF protein structure data indicate that TNFs have very low percentage of a-helices, 
approximately 50% R-sheets and 50% coils. PROF secondary structure prediction is better in 
this regard than PSI-PRED although PROF also has the similar problem. We do not intend 
to evaluate performance of different secondary structure prediction algorithms in this paper, 
but wish to emphasize that accuracy of secondary structure prediction constitutes a limiting 
factor for effectiveness of secondary structure profiling adjustment in improving protein 
structure threading. Secondary structure profiling adjustment is able to improve performance 
of this threading scheme given reasonable secondary structure prediction accuracy. 
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Table 2. Comparison in rank of known TNFs between fold recognition with 








TNF 11 1St 2nd 
Cachectin 2na 1St 
CD40 3rd Stn 
TNF 10 4th 3rd 
APO-1 5th ~th 
Lymphotoxin beta 6th 9th 
TNF 1 S 7th 6th 
TNF 14 gth 8th 
Lymphotoxin alpha 9th 4th 
EDA l 0th 19th 
TNF 13b 66tH 10th 
CD70 95th 15th
TNF9 5 34th 395th
TNF4 7 9 5th 121St
Table 3. Influence of secondary structure prediction on performance of fold recognition 
(length 152) 
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3. Sensitivity of sequence length on fold recognition performance 
A difficulty associated with agap-allowed protein structure threading scheme is that 
gap-allowed threading is sequence length dependent. In this study, the impact of sequence 
length on threading performance was systematically investigated on known human TNFs, 
known TNFs from different species, and the selected human genome protein sequences after 
secondary structure initial screening. The experiment was carried out on 11 different 
sequence lengths, i.e. 144, 148, 152, 1 S 5, 15 8, 162, 166, 170, 174, 178, and 182. Because 
TNFs mainly locate on C-terminus, the protein sequences were truncated from C-terminal 
ends. Two scoring approaches, maximal score and average score, are used to rank protein 
sequences. The target recognition capacity of our scheme was systematically investigated on 
eleven human genome protein sequence (after secondary structure composition screening) 
sets of different lengths (Fig. 7). Signal to noise ratio is a good measure for evaluating 
sensitivity of target recognition, which is usually defined as a ratio of number of true 
positives and number of false positives. However, in the scenario of genome-wide molecular 
target recognition, a significant portion of genomic sequences are functionally unknown. 
Under this circumstance, the selected candidates with no functional annotation might be 
either true targets or false positives. Hence, it is inappropriate to categorize unknown 
sequences into false positives without evidence, and therefore, it is not feasible to compute 
signal-noise ratio in this scenario. Percentage of known targets (TNFs) in total number of 
selected candidates is considered as an alternative to signal-noise ratio in evaluating 
sensitivity of the scheme in target recognition. Percentage of known TNFs in selected 
candidates (% signal in figure 7) is defined as proportion of known TNFs with respect to 
selected candidates at a certain cut-off. Percentage of selected candidates (% selected in 
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figure 7) is defined as proportion of selected candidates at a certain cut-off with respect to 
total number of sequences in the sequence set. 
Both maximal scoring and average scoring are studied. For maximal scoring, 
changes of percentage of selected candidates (% selected) and percentage of known TNFs in 
selected candidates (% signal) show a similar pattern between different sequence lengths (Fig. 
7). %selected curve starts a sharp decrease at maximal score 0; %signal curve starts a sharp 
increase around maximal score 25 (Fig. 7). The intersection points of the two curves are 
between 20 and 30, with slight variations between different sequence lengths. Roughly, the 
intersection maximal scores of length 144, 148, 152, 1 S5, 158 are less than 25; the scores of 
length 162, 166, 170, and 178 are around 25; and the scores of length 178 and 182 are higher 
than 25 (Fig. 7). Although intersection score is a good measure for characterizing overall 
behavior of target recognition, intersection scores are not feasible cut-off for target 
recognition because a significant number of false positives maybe selected as candidates. 
For example, for length 162, 190 sequences (6% of total number of sequences) are selected 
as candidates, and percentage of known TNFs in selected candidates is only 6.3%. Therefore, 
a more stringent cut-off should be employed to select candidates. An arbitrary stringent 
maximal score cut-off (3 7) and a marginal maximal score cut-off (31) were used to selected 
candidates, respectively. For instance, for sequence length 162, 13 sequences (0.5% of total 
number of sequences) are selected as candidates if stringent cut-off is applied, and percentage 
of known TNFs in selected candidates is 77%. By use of this cut-off, 10 out of 15 (67%) 
known TNFs are able to be recognized. If cut-off is relaxed to marginal cut-off (31), 50 
sequences (1.8% of total number of sequences) are selected with percentage of known TNFs 
in selected candidates being 24%, and 12 out of 15 (80%) known TNFs can be recognized. 
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The range of average relative scores is narrower than that of maximal relative scores. 
Using average scoring, changes of percentage of selected candidates (% selected) and 
percentage of known TNFs in selected candidates are similar between different lengths (Fig. 
7). The average relative scores at which %selected and %signal curves intersect are 
between 11 and 15. It is observed that the intersection scores slightly increase with sequence 
length. Similarly, a stringent average score cut-off (23.4) and a marginal average score cut-
off (19.8) were employed to select candidates. The stringent and marginal average score cut-
offs are mapped from corresponding stringent and marginal maximal score cut-offs based on 
same rank in the ordered score list of length 162. This rank-based mapping is to make 
average score cut-offs comparable to maximal score cut-offs. 
One concern is that scores are dependent on sequence length in gap-allowed threading, 
and fixed cut-offs may miss targets or allow too many false positives. Fig. 8 shows changes 
of maximal relative scores (Fig. 8A) and average relative scores (Fig. 8B) of the known 
TNFs with changes in sequence length. The scores of some TNFs vary with sequence length, 
however, they can be recognized because their scores are higher than cut-offs at most of 
lengths. Lymphotoxin alpha, Lymphotoxin beta, CD40, APO-1, TNF 10, TNF 11, TNF 15, 
TNF 17, TNF 13b, and cachectin belong to this case. On the other hand, the scores of TNF4 
and TNF 18 are lower than marginal cut-offs at all lengths, and therefore the two are not able 
to be recognized with the used cut-offs at any length. 
Complication arises from the targets whose recognition is more dependent on 
sequence length. For example, the scores of CD-70 vary with sequence length, reaching the 
highest scores at sequence length 152 (Fig. 8). The maximal and average scores of CD-70 
are higher than stringent cut-offs only at length 152 (Fig. 8); CD-70 is recognized at the other 
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lengths (Table 6). EDA is able to be recognized only when sequence length is less than 162 
in the case of maximal score or less than 155 in the case of average score. TNF9 is able to be 
recognized with marginal maximal score cut-off at length 158, however, the target is not 
recognizable at any other combination ofcut-offs and sequence length. For this type of 
targets, whether or not targets can be recognized at a certain cut-off is relevant to sequence 
length. The difficulty is that there is no constant way to adjust cut-offs based on sequence 
length for all targets. Therefore, it is necessary to try different lengths and search for the 
length at which the best recognition can be achieved. 
The known human TNF sequences and the known TNF sequences from diverse 
species are used to investigate the effects of sequence length on candidate selection (table 4). 
For maximal scoring, the highest number of TNFs (67 out of 80) can be recognized at length 
152 when the stringent cut-off is applied to the TNFs from diverse species, and the highest 
number of TNFs (71 out of 80) can be recognized at the length 155 when the marginal cut- 
off is applied to the same set. Similarly, the highest number of TNFs is able to be recognized 
at length 152 in the human TNF set no matter which cut-off (stringent or marginal) is used. 
For average scoring, the highest number of TNFs can be recognized at shorter lengths 148, 
152, and 155. Generally, the relatively shorter lengths (between 148 and 155) are good for 
TNF recognition. 
It is of interest that average scoring can recognize more TNF targets than maximal 
scoring. In the cross species TNF set, average scoring is capable of recognize one more TNF 
than maximal scoring in the case of stringent cut-off. Similarly, average scoring can identify 
two more TNFs than maximal scoring in the human TNF set in the case of stringent cut-off. 
However, average scoring performs the same with maximal scoring for both sets in the case 
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of marginal cut-off. Average scoring takes average of relative scores of a sequence on all 
TNF structures in the database. True TNF candidates are expected to be similar to most of 
known TNF structures in the database; competitive false positives might happen to have a 
high score for a particular TNF structure, however, false positives have little chance to have 
high scores for most of known TNF structures. Therefore, average scoring maybe capable 
of averaging out those false positives which happen to have a high score for a particular TNF 
structure. Meanwhile, average scoring can be more sensitive to true TNF candidates whose 
maximal scores are not very outstanding. So average scoring is more useful in the case of 
very stringent selection. 
The human genome sequences pre-selected based on secondary structure composition 
is also used for investigation in a scale-up scenario. In table 5, recognition power measures 
proportion of recognized TNFs in the total number of TNFs in the set, and accuracy measures 
proportion of recognized TNFs in the total number of selected candidates. For both maximal 
scoring and average scoring, using marginal cut-off can increase the recognition power at the 
price of decreasing accuracy and possibly allowing more false positives. In the case of 
maximal scoring, using the stringent cut-off, the recognition power at the length 152 is higher 
than that at the length 148; on the other hand, the accuracy at the length 152 is lower than 
that at length 148. This situation becomes more obvious for the marginal cut-off. Less 
number of TNFs (11 out of 15) can be identified at length 148 than those at the lengths 152, 
15 5, 15 8, and 162 (12 out of 1 S), however, number of selected candidates at 148 is lower 
than those at the lengths mentioned above. There is a tradeoff between high recognition 
power and allowance of more candidates against each other. Hence, determination of cut-off 
and length needs careful evaluation depending on purpose of search. In the case of average 
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scoring, both the highest recognition power and the highest accuracy can be achieved at the 
length 152 in stringent case; both recognition power and accuracy reach the highest at the 
length 144 in marginal case. So average scoring seems relatively easier for determining cut-
off and sequence length. Furthermore, average scoring is able to identify one more TNF than 
maximal scoring in the stringent case. 
Table 6 summarizes rank of TNFs based on maximal scores and average scores at 
different sequence lengths. Rank of TNFs varies with sequence length as well as different 
scorings. Basically, the top ten TNFs are recognizable at most of lengths. Rank of EDA 
becomes worse with sequence length increasing. CD70 and TNF9 reach their best rank at 
152 and 158, respectively, and then become worse with length. To put together, selection of 
sequence length and cut-off is critical for target recognition. 
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Fig. 7. Changes of percentage of selected candidates (% selected) and percentage of known 
TNFs in selected candidates (% signal) with changes of sequence length. %selected = 
number of sequences selected based on cut-off /total number of sequences; %signal = 
known TNFs selected based on cut-off /number of sequences selected based on cut-off. 
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Fig. 8. Changes of maximal scores (A) and average scores of known human TI~1F related 
proteins over sequence length. 
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Table 4. Maximal scores and average scores of known human and cross-species TNF related 
proteins at different sequence lengths (number of recognized TNFs /total number of TNFs) 
Length Pool of different species Human Pool of different species Human 
Score?37 Score>31 Score>37 Score>31 Score?23.4 Score? 19.8 Score>23.4 Score? 19.8 
144 64/77 67/77 10/18 12/18 65/77 68/77 12/18 13/18 
148 64/77 70/77 11/18 13/18 66/77 69/77 13/18 14/18 
152 68/77 72/77 12/18 14/18 67/77 72/77 14/18 15/18 
155 64/77 72/77 11/18 14/18 66/77 70/77 12/18 14/18 
158 64/77 71/77 11/18 14/18 64/77 69/77 11/18 13/18 
162 64/77 69/77 11/18 13/18 64/77 65/77 11/18 11/18 
166 64/77 68/77 11/18 12/18 65/77 67/77 12/18 12/18 
170 63/77 66/77 11/18 12/18 62/77 65/77 10/18 11/18 
174 59/77 66/77 11/18 12/18 60/77 65/77 11/18 11/18 
178 55/77 65/77 12/18 13/18 55/77 61/77 11/18 11/18 
182 53/77 65/77 10/18 13/18 53/77 65/77 10/18 12/18 
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Table 5. The recognition power and accuracy of known human TNF related proteins in human 
genome sequences at different sequence (recognition power =recognized TNFs /total TNFs; 
accuracy =total number of sequences with score greater than or equal to cut-offl 
Length 
Maximal Score Average Score 










144 9/15 9/12 11/15 11/35 11/15 11/17 12/15 12/27 
148 10/15 10/12 11/15 11/33 11/15 11/16 11/15 11/28 
152 11/15 11/16 12/15 12/35 12/15 12/15 12/15 12/31 
155 10/15 10/13 12/15 12/47 10/15 10/14 11/15 11/32 
158 10/15 10/15 12/15 12/45 10/15 10/13 11/15 11/37 
162 10/ 15 10/ 13 12/ 15 12/5 0 10/ 15 10/ 15 10/ 15 10/2 8 
166 10/ 15 10/ 14 10/ 15 10/47 10/ 15 10/ 15 10/ 15 10/28 
17 0 10/ 15 10/ 14 11 / 15 11 /4 0 10/ 15 10/ 13 10/ 15 10/3 0 
174 10/ 15 10/ 15 10/ 15 10/40 9/ 15 9/ 13 10/ 15 10/34 
17 8 9/ 15 9/ 15 10/ 15 10/4 8 10/ 15 10/ 19 10/ 15 10/3 8 
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4. Genome-wide search for potential TNF related ligand proteins in human and 
Arabidopsis genomes 
The stringent maximal scoring cut-off (37) was used to select sequences with the highest ranks 
at each of eleven different lengths. Known TNF related ligand proteins were removed from the 
candidate lists. Table 8 summarizes rank of the protein sequences with a similar fold to known 
TNF related proteins selected in human genome. 14741794 and 14741802 are selected at 8 and 
4 out of 11 lengths, respectively. The current functional annotations of the protein sequences 
are B7-H 1 proteins which are co-stimulatory molecules involved in cancer, rheumatoid arthritis 
and regulation of cellular and hormonal immune responses [20, 21, 22] . 14726804 is selected 
at 5 out of 11 lengths. According to the current functional annotation, the protein sequence is 
similar to complement 1-Q (C 1 q) subcomponent. C-1-q is involved in cell-cell signaling [23, 
24]. 14741766, 14785127, 13631907 are selected twice. 14741766 is similar to MYELOID 
cell surface antigen CD33. 14785127 is erythrocyte membrane protein band 4.2. 13639331 is 
mitogen-activated protein kinase. These proteins seem closely related to signaling and 
regulation of immune response. Two protein sequences 14724535 and 13639331, not 
functionally annotated, are selected 3 and 2 times at different lengths. 
The protein structure threading was also carried out on the pre-selected Arabidopsis 
genome protein sequence set at different lengths. The stringent maximal score and average 
score cut-offs are applied to make selections. Table 9 and 10 summarize the rank of the 
selected candidates in A~abidopsis genome at different lengths based on maximal scores and 
average scores, respectively. For both maximal scoring and average scoring, 15239526 and 
15224467 are heavily selected at multiple lengths. According to the current annotation, 
15239526 is similar to CHP-rich zinc finger protein. In mammalian systems, zinc finger 
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protein is a transcription factor that plays an important role in the regulation of lymphocyte 
differentiation [25]. The protein is similar to Arabidopsis RAR1 which is critical in signaling 
process essential for plant system against pathogens [26]. 
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Table 8. Summary of rank of candidates in human genome at different lengths based on 
maximal scores 
Sequence length 
144 148 152 155 158 162 166 170 174 178 182 
.14741794 11 1l 11 9' 8 8 9 8 




1..4726.804 16 13 13 15 13 
14785127 11 13 




14741802 i0 9 _ _ 10 7 10 
14751912 13 
13631907 14 14 
14724535 15 14 17 
13639331 11 6 
14733176 13 14 
14784558 16 
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Table 9. Summary of rank of candidates in A~abidopsis genome at different lengths based on 
maximal scores 
Sequence length 
144 148 152 155 158 162 166 170 174 178 182 
15230378 1 1 1 4 
15228901 2 




15239526 4 5 5 
_
2 1 1 
15240695 5 
15.224467 2 1 l l 2 2 1 1 
15237576 4 
15223548 6 2 
15238382 3 2 2 
15242937 6 2 1 
15233827 3 




15232490 4 5 
15222720 5 3 







Table 10. Summary of rank of candidates in Arabiclopsis genome at different lengths based on 
average scores 
Sequence length 
144 148 152 155 158 162 166 170 174 178 182 
15239526 1 2 3 2 1 l 1 1 1 
15224467 1 2 3 2 2 
15231224 1 1 






Genome sequencing projects have been producing explosive mass of linear sequence 
data in a variety of species. The ultimate goal of genomics research is to understand structures 
and functions in genome scale. Due to nature of research methodology, structural and 
functional research is significantly lagged behind genome sequencing. Hence, currently 
majority of genome scale functional annotation efforts largely rely on sequence similarity based 
approach, such as the most popular sequence search algorithm BLAST and HMM [27, 28]. 
However, sequence similarity based functional prediction may attenuate in its power with 
decrease of sequence similarity. Sequence similarity based approach may not be robust in the 
"twilight zone" and the less. Hence, more evidences from structural or/and functional data are 
needed for improvement. Proteins with minimum sequence similarity may share a similar fold 
[ 10]; proteins with a similar fold are likely to be functionally related. In the case of TNF 
related proteins, the protein sequences have approximately 25%~30% sequence similarity, 
however most of TNF related proteins share a similar fold class [5, 8] . Therefore, structural 
information can provide more insight to recognition of TNF related proteins. Moreover, 
structural information can facilitate genome scale target search by reducing search space. In 
this study, the initial screening based on secondary structure composition very significantly 
reduce search space of fold recognition and improve overall quality (measured by score) of 
search space. Practically, this is very meaningful because protein structure threading is 
computationally very demanding. 
The two major components in protein structure threading scheme are sequence-structure 
alignment approach and scoring scheme for model evaluation. In our scheme, global gap-
allowed sequence-structure alignment is used to generate models. The advantage of this 
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approach is that a relatively flexible set of alternative folds. However, this approach may result 
in the problem of sequence length dependency. In this study, we investigated behavior of 
threading scores at different sequence lengths. For example, the scores of the known TNF 
related proteins vary with sequence length (Fig. 8). For those with top scores or low scores, 
changing behavior of the known TNFs with length does not affect candidate selection based on 
a certain cut-off. However, for the proteins whose scores fluctuate around a certain cut-off 
with change of length, choice of sequence length may have an influence on whether proteins 
are able to be selected under a certain cut-off. In the present study, recognition of CD70 and 
EDA largely depends on sequence length. Generally, the closer lengths of query sequence and 
template structure are, the better recognition is. Also, a large difference in length between 
query sequence and template structure may bring in more false positives. For instance, in the 
case of longer TNF sequences (length 178 and 182), recognition power (proportion of 
recognized known TNFs with respect to total known TNFs in the set) and accuracy (proportion 
of known TNFs with respect to total number of selected candidates) attenuate. 
Scoring scheme is very critical for sequence-structure model optimization and selection. 
The raw scoring in this scheme is mainly on the basis of inter-residue contact energy 
minimization. Contact energy is estimated using twenty q values derived from Miyazawa-
Jernigan effective inter-residue contact energy model [l, 2]. Because the twenty q values are 
mainly relevant to amino acid residue hydrophobicity [2], energy minimization solely founded 
on this may achieve global optimization but may not be able to optimize local sequence-
structure relationship. Incorporation of secondary structure profile into the scheme can 
improve performance of the scheme by adjusting local sequence-structure relationship. It 
should be stressed that secondary structure profiles of genome protein sequences are predicted 
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by secondary structure prediction programs; therefore quality of prediction has a critical impact 
on effect of local sequence-structure adjustment. Moreover, random sequence shuffling is 
employed to generate empirical distribution and calculate relative score or/and Z score [31 ] . 
This is aimed at reducing bias due to sequence composition. Maximal scoring and average 
scoring are compared in this study. It turns out that average scoring performs better than 
maximal scoring. Non-TNF proteins has chance to align with a certain template structure very 
well and get a high score although the chance is much less than TNF related proteins. However, 
as compared with TNF related proteins, the chance of non-TNF proteins being aligned well 
with all template structures is little. Thus, average scoring takes this into account and evaluate 
upon all 17 sequence-structure models instead of only the best one, therefore reducing false 
positives. In genome scale experiment, it is very important to reduce number of false positives. 
More stringent cut-offs can effectively reduce number of selected candidates and meanwhile 
improve accuracy (Fig. 7). But it maybe at the risk of missing true positives. Therefore, 
practically, determination of cut-off stringency depends on search purpose and feasibility of 
follow-up tests. 
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Appendix A. List of the known TNF superfamily members from different species 
>sp~Q9Y275~T13B_HUMAN Tumor necrosis factor ligand superfamily member 13B 
(TNF-and APOL- related leukocyte expressed ligand 1) (TALL-1) (B lymphocyte 
stimulator) (BLyS) (B cell -activating factor) (BAFF) (Dendritic cell -





>sp~Q9WU72~T13B_MOUSE Tumor necrosis factor ligand superfamily member 13B (B 






>sp~P50591~TN10_HUMAN Tumor necrosis factor ligand superfamily member 10 
(TNF-related apoptosis inducing ligand) (TRAIL protein) (Apo-2 ligand) (Apo-





>sp~P50592~TN10_MOUSE Tumor necrosis factor ligand superfamily member 10 






>sp~O14788ITN11_HUMAN Tumor necrosis factor ligand superfamily member 11 
(Receptor activator of nuclear factor kappa B ligand) (RANKL) (TNF-related 
activation-induced cytokine) (TRANCE) (Osteoprotegerin ligand) (OPGL) 






>spIO35235ITN11_MOUSE Tumor necrosis factor ligand superfamily member 11 
(Receptor activator of nuclear factor kappa B ligand) (RANKL) (TNF-related 
activation- induced cytokine) (TRANCE) (Osteoprotegerin ligand) (OPGL) 







>sp~O75888ITN13_HUMAN Tumor necrosis factor ligand superfamily member 13 (A 
proliferation- inducing ligand) (APRIL) (TNF-and APOL-related leukocyte 






>spIO43557~TN14_HUMAN Tumor necrosis factor ligand superfamily member 14 





>sp~Q9UNG2~TNl8_HUMAN Tumor necrosis factor ligand superfamily member 18 
(Glucocorticoid-induced TNF-related ligand) (hGITRL) (Activation-inducible 




>sp~Q06599~TNFA BOVIN Tumor necrosis factor precursor (TNF-alpha) (Cachectin) 





>spIP51742~TNFA CANFA Tumor necrosis factor precursor (TNF-alpha) (Cachectin) 





>spIP13296ITNFA CAPRI Tumor necrosis factor precursor (TNF-alpha) (Cachectin) 




>spIP51435~TNFA CAVPO Tumor necrosis factor precursor (TNF-alpha) (Cachectin) 





>spIP51743~TNFA CEREL Tumor necrosis factor precursor (TNF-alpha) (Cachectin) 






>spIP19101ITNFA FELCA Tumor necrosis factor precursor (TNF-alpha) (Cachectin) 





>spIP29553~TNFA HORSE Tumor necrosis factor precursor (TNF-alpha) (Cachectin) 





>spIP01375~TNFA HUMAN Tumor necrosis factor precursor (TNF-alpha) (Cachectin) 





>spIO77764ITNFA MACEU Tumor necrosis factor precursor (TNF-alpha) (Cachectin) 





>spIP79337~TNFA MACFA Tumor necrosis factor precursor (TNF-alpha) (Cachectin) 





>sp~P48094~TNFA MACMU Tumor necrosis factor precursor (TNF-alpha) (Cachectin) 





>sp~O35734~TNFA MARMO Tumor necrosis factor precursor (TNF-alpha) (Cachectin) 





>sp~P06804~TNFA MOUSE Tumor necrosis factor precursor (TNF-alpha) (Cachectin) 






>spIO77510~TNFA PAPHU Tumor necrosis factor precursor (TNF-alpha) (Cachectin) 





>sp~P33620~TNFA PAPSP Tumor necrosis factor precursor (TNF-alpha) (Cachectin) 





>spIP36939~TNFA PERLE Tumor necrosis factor precursor (TNF-alpha) (Cachectin) 





>sp~P23563~TNFA PIG Tumor necrosis factor precursor (TNF-alpha) (Cachectin) 





>sp~P04924ITNFA RABIT Tumor necrosis factor precursor (TNF-alpha) (Cachectin) 





>spIP16599ITNFA RAT Tumor necrosis factor precursor (TNF-alpha) (Cachectin) 





>sp~P23383~TNFA SHEEP Tumor necrosis factor precursor (TNF-alpha) (Cachectin) 






>sp~P79374~TNFA TRIVU Tumor necrosis factor precursor (TNF-alpha) (Cachectin) 





>sp~Q06643~TNFC_HUMAN Lymphotoxin-beta (LT-beta) (Tumor necrosis factor C) 





>sp~P41155~TNFC_MOUSE Lymphotoxin-beta (LT-beta) (Tumor necrosis factor C) 



















>trIQ91ZL4 Tumor necrosis factor alpha (Fragment) - Sigmodon hispidus 




>tr~Q99NDl Tumor necrosis factor (Fragment) - Tamiasciurus hudsonicus 



































>tr~Q9BEF3 Tumor necrosis factor (Fragment) - Didelphis marsupialis 














>tr~Q9BEGl Tumor necrosis factor (Fragment) - Bradypus tridactylus (Pale-


























>sp~Q92838~EDA HUMAN Ectodysplasin A (Ectodermal dysplasia protein) (EDA 







>sp~P29965ITNF5_HUMAN CD40 ligand (CD40-L) (TNF-related activation protein) 





>sp~P48023~FASL_HUMAN FAS antigen ligand (Apoptosis antigen ligand) (APTL) 





>spIP23510ITNF4_HUMAN OX40 ligand (OX40L) (Glycoprotein GP34) (TAX-





>sp~P32971ITNF8_HUMAN CD30 ligand (CD30-L) (CD153 antigen) - Homo sapiens 














>spIP01374~TNFB_HUMAN Lymphotoxin-alpha precursor (LT-alpha) (TNF-beta) -




>trIO43508 TNF-RELATED WEAK INDUCER OF APOPTOSIS (TWEAK) (APO3 LIGAND) 



































>spIP51749~TNF5_BOVIN CD40 ligand (TNF-related activation protein) (TRAP) (T 










>sp~097605~TNF5_FELCA CD40 ligand (CD154 antigen) - Felis silvestris catus 





>spIP27548~TNF5_MOUSE CD40 ligand (TNF-related activation protein) (TRAP) (T 















>sp~Q9XT48~TNFB_MACEU Lymphotoxin-alpha precursor (LT-alpha) (TNF-beta) -





>sp~P09225ITNFB_MOUSE Lymphotoxin-alpha precursor (LT-alpha) (TNF-beta) -









>spIP10154~TNFB_RABIT Lymphotoxin-alpha precursor (LT-alpha) (TNF-beta) -




>sp~Q06332ITNFB_RAT Lymphotoxin-alpha precursor (LT-alpha) (TNF-beta) -





Appendix B. PSI-BLAST results of known human TNFs, and C-1-Q proteins 





[species] (E value) 
Pfam 
(E value) 
TNF11 014788 12643360 14753650 TNFSF101 
[Dario rerio] (1 e-18) 
TNF domain 
(6.6e-11) 





CD40 P29965 231718 14764991 Osteoclast 
differentiation factor 




TNF 10 P50591 1730051 11435131 TNFSF 101 
[Dario rerio] (3 e-24) 
TNF domain 
(2.3 e-13 ) 
APO-1 
(TNF6) 




















P01374 135940 14782294 TNFA 
[Lama. glama] (1 e-18) 
TNF domain 
(1.7e-5 8) 
EDA 092838 6166135 14786080 Top 24 hits are related 
to EDA; the hits with 
E-value lower than 




TNF family (potential) 
(0.021) 
TNF13b Q9Y275 13124573 14752757 TNF13 (APRIL) 
[Mus musculus] (2e- 
18) 
There are no Pfam-A 




CD70 P32970 21431837 14758986 No TNFs other than 
CD70 can be picked 
with E-value lower 





TNF9 P41273 728739 13649300 No TNFs other than 
TNF9 can be picked 
with E-value lower 
than 0.001. TNF 14 
[Homo sapiens] (0.45) 
TNF domain 
(8.3e-52) 
TNF4 P23510 121540 14737250 No other TNFs other 
than TNF4 can be 
picked with E-value 
lower than 0.001. 





TNF8 P32971 416777 11427718 No other TNFs other 
than TNF8 can be 
picked with E-value 
lower than 0.001. 




TNF 18 Q9LTNG2 13124621 11428078 No other TNFs other 
than TNF 18 can be 
picked with E-value 
lower than 0.001. 
TNFS [Gallus gallus] 
(0.02) 
No match 














* In PSI-BLAST search, a top hit, except for self and hits with same annotation from 
other species, is listed for each of known TNFs and C-1-Q. 
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Appendix C. The sequences of the potential TNF-like hits in human and Arabidopsis 
genomes recognized by the protein structure threading scheme 
Human genome: 
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